Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
24.2 HKD | +5.68% | -1.03% | +15.31% |
May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
May. 14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.31% | 940M | |
-2.95% | 89.49B | |
+2.50% | 40.67B | |
-12.01% | 33.15B | |
+62.74% | 26.45B | |
-19.79% | 14.69B | |
-8.58% | 12.89B | |
-12.34% | 11.54B | |
-43.92% | 11.34B | |
+4.27% | 8.84B |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Transcript : Calliditas Therapeutics AB, Everest Medicines Limited - Special Call